NCT05027386

Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.

CompletedPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2021-08-26Est. Completion: 2026-02-04

Enrollment target: 125 participants

Locations

Recurrent GanglioneuroblastomaRecurrent NeuroblastomaRefractory GanglioneuroblastomaRefractory Neuroblastoma

This phase I/II trial studies the side effects and best dose of iberdomide when given together with chemoimmunotherapy d…

Multiple LocationsEst. completion Sep 30, 2029

Ganglioneuroblastoma, NodularNeuroblastoma

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.